Tuesday, July 31, 2018 11:31:38 AM
My guess is because this is an animal-derived biologic as opposed to plant based.
Nonetheless, i was told that the CPRC at GSA was in the process of creating a new SIN# classification and that two (2) clinical trials were being conducted to compare efficacy to other opiods. During the interim, the VA procurement staff was advised to order the product directly from the EuroAmerican website at the same bulk discount as initially provided to GSA.
I was told that sales were very good and I'm sure that Debra has increased her sales campaign since my discussion with her a few months ago; At that time, her team was meeting with the medical director heads at each specific VA to get the word out... As I've indicated previously she uses the product herself and is a firm believer in its efficacy.
Like Mav, I don't frequent this message board as often but i still have a very sizeable position and i plan to sell a few million responsibly when this share price is where it should logically and fundamentally be i.e., many pennies from here... I have full confidence that this will get there very shortly.
Until then, I will wait and add as my other investments gain in value.
Best of luck to all here... no worries
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM